Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 1
2003 2
2004 4
2005 5
2006 2
2007 6
2008 4
2009 4
2010 1
2011 3
2012 4
2013 1
2015 2
2016 5
2017 7
2018 12
2019 9
2020 13
2021 16
2022 20
2023 22
2024 8

Text availability

Article attribute

Article type

Publication date

Search Results

138 results

Results by year

Filters applied: . Clear all
Page 1
Herbal formula BaWeiBaiDuSan alleviates polymicrobial sepsis-induced liver injury via increasing the gut microbiota Lactobacillus johnsonii and regulating macrophage anti-inflammatory activity in mice.
Fan X, Mai C, Zuo L, Huang J, Xie C, Jiang Z, Li R, Yao X, Fan X, Wu Q, Yan P, Liu L, Chen J, Xie Y, Leung EL. Fan X, et al. Among authors: xie c. Acta Pharm Sin B. 2023 Mar;13(3):1164-1179. doi: 10.1016/j.apsb.2022.10.016. Epub 2022 Oct 22. Acta Pharm Sin B. 2023. PMID: 36970196 Free PMC article.
β-Elemene enhances erlotinib sensitivity through induction of ferroptosis by upregulating lncRNA H19 in EGFR-mutant non-small cell lung cancer.
Xu C, Jiang ZB, Shao L, Zhao ZM, Fan XX, Sui X, Yu LL, Wang XR, Zhang RN, Wang WJ, Xie YJ, Zhang YZ, Nie XW, Xie C, Huang JM, Wang J, Wang J, Leung EL, Wu QB. Xu C, et al. Among authors: xie c. Pharmacol Res. 2023 May;191:106739. doi: 10.1016/j.phrs.2023.106739. Epub 2023 Mar 21. Pharmacol Res. 2023. PMID: 36948327 Free article.
Bacteria-based nanodrug for anticancer therapy.
Xie YJ, Huang M, Li D, Hou JC, Liang HH, Nasim AA, Huang JM, Xie C, Leung EL, Fan XX. Xie YJ, et al. Among authors: xie c. Pharmacol Res. 2022 Aug;182:106282. doi: 10.1016/j.phrs.2022.106282. Epub 2022 Jun 1. Pharmacol Res. 2022. PMID: 35662630
Application of CRISPR/Cas9-based genome editing in ecotoxicology.
Zhao F, Ding X, Liu Z, Yan X, Chen Y, Jiang Y, Chen S, Wang Y, Kang T, Xie C, He M, Zheng J. Zhao F, et al. Among authors: xie c. Environ Pollut. 2023 Nov 1;336:122458. doi: 10.1016/j.envpol.2023.122458. Epub 2023 Aug 24. Environ Pollut. 2023. PMID: 37633433 Review.
CERS4 predicts positive anti-PD-1 response and promotes immunomodulation through Rhob-mediated suppression of CD8+Tim3+ exhausted T cells in non-small cell lung cancer.
Wang J, Li RZ, Wang WJ, Pan HD, Xie C, Yau LF, Wang XX, Long WL, Chen RH, Liang TL, Ma LR, Li JX, Huang JM, Wu QB, Liu L, He JX, Leung EL. Wang J, et al. Among authors: xie c. Pharmacol Res. 2023 Aug;194:106850. doi: 10.1016/j.phrs.2023.106850. Epub 2023 Jul 13. Pharmacol Res. 2023. PMID: 37453674 Free article.
DNA Origami Post-Processing by CRISPR-Cas12a.
Xiong Q, Xie C, Zhang Z, Liu L, Powell JT, Shen Q, Lin C. Xiong Q, et al. Among authors: xie c. Angew Chem Int Ed Engl. 2020 Mar 2;59(10):3956-3960. doi: 10.1002/anie.201915555. Epub 2020 Jan 28. Angew Chem Int Ed Engl. 2020. PMID: 31883145 Free PMC article.
138 results